Mark Greenwald to Opioid-Related Disorders
This is a "connection" page, showing publications Mark Greenwald has written about Opioid-Related Disorders.
Connection Strength
1.524
-
A Neuropharmacological Model to Explain Buprenorphine Induction Challenges. Ann Emerg Med. 2022 12; 80(6):509-524.
Score: 0.577
-
A Virtual Reality Meditative Intervention Modulates Pain and the Pain Neuromatrix in Patients with Opioid Use Disorder. Pain Med. 2021 Nov 26; 22(11):2739-2753.
Score: 0.550
-
48-hour Induction of Transdermal Buprenorphine to Sublingual Buprenorphine/Naloxone: The IPPAS Method. J Addict Med. 2023 Mar-Apr 01; 17(2):233-236.
Score: 0.146
-
Synergistic Effect of Ketamine and Buprenorphine Observed in the Treatment of Buprenorphine Precipitated Opioid Withdrawal in a Patient With Fentanyl Use. J Addict Med. 2022 Jul-Aug 01; 16(4):483-487.
Score: 0.137
-
Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2019 02 23; 393(10173):778-790.
Score: 0.114